Stem Cell

The development of stem cells  has led to a potential new paradigm in cellular therapeutics, including the possibility of producing patient-specific and disease-specific cells. Stem cell therapy is being explored across various diseases including diabetes, cancer, neuro-degenerative diseases, and also for injuries, transplants and other therapeutic areas. Krishgen provides a range of ELISA for quantification of biomarkers, growth factors and cytokines induced in stem cells.